Takeda Pharmaceuticals International AG Ireland Branch
8 products tracked · names used in filings: Takeda Pharmaceuticals International AG Ireland Branch
Upcoming milestones
No upcoming milestones listed.
Recent milestones
No recent milestones.
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Qdenga dengue tetravalent vaccine (live, attenuated) | Authorised | 2022-12-05 |
| 🇪🇺 | Livtencity maribavir | Authorised | 2022-11-09 |
| 🇪🇺 | Takhzyro lanadelumab | Authorised | 2018-11-22 |
| 🇪🇺 | Natpar parathyroid hormone | Withdrawn | 2017-04-24 |
| 🇪🇺 | Plenadren hydrocortisone | Authorised | 2011-11-03 |
| 🇪🇺 | Vpriv velaglucerase alfa | Authorised | 2010-08-26 |
| 🇪🇺 | Elaprase idursulfase | Authorised | 2007-01-08 |
| 🇪🇺 | Replagal agalsidase alfa | Authorised | 2001-08-03 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.